Here, we have assessed how the combination of several molecules associated to several aspects of PDAC physiopathology, such as the inflammatory component and the growth factor axis, together with the tumor markers CA 19–9 and CEA could differentiate between PDAC and CP. Here, CP is linked to neoplasm.